Literature DB >> 10378561

Decreasing catheter colonization through the use of an antiseptic-impregnated catheter: a continuous quality improvement project.

G R Collin1.   

Abstract

STUDY
OBJECTIVES: To evaluate the use of an antiseptic-impregnated (chlorhexidine and silver sulfadiazine) catheter for the prevention of catheter colonization and catheter-related bloodstream infection (CR-BSI). Then, based on these findings, to implement changes in hospital policy and to assess their effect on a hospital service.
DESIGN: Prospective, randomized, controlled (phase I); prospective, concurrent data collection (phase II).
SETTING: Tertiary referral hospital with level 1 trauma center. PATIENTS: Patients > 12 years of age with central venous catheters placed while they were in the emergency room, neurotrauma ICU, or medical/surgical ICU from May through December, 1995 (phase I). All patients > 12 years of age on the trauma service admitted from November 16, 1996, through November 15, 1997 (phase II).
INTERVENTIONS: Randomization table determined whether the patient would receive an antiseptic-impregnated catheter (AIC) or nonimpregnated catheter (NIC) (phase I). All removed or exchanged catheters were sent for semiquantitative culture. In phase II, only AICs were used; "length of time" and "fever" were discouraged as reasons for catheter exchange or removal; and only the tip was sent for culture. MEASUREMENTS AND
RESULTS: In phase I, there were 139 catheters placed in 60 patients in the NIC group and 98 catheters placed in 55 patients in the AIC group. Two catheters (2.0/100 catheters) in the AIC group were found to be colonized, compared with 25 (18.0/100 catheters) in the NIC group (p = 0.001). The catheter colonization rates were 2.27/1,000 catheter days (AIC) and 24.68/1,000 catheter days (NIC) (p < 0.001), while the CR-BSI rates were 1.14/1,000 catheter days (AIC) and 3.9.5/1,000 catheter days (NIC) (p = 0.31). The reason for each catheter removal/exchange was noted, and only "positive blood culture" was statistically significant overall. The tip segment was found to be positive more often than the intracutaneous segment. In phase II, there were 213 AICs placed in 101 patients. The colonization rate was 3.8/100 catheters (4.52/1,000 catheter days), and CR-BSI rate was 1.0/100 catheters (0.6/1,000 catheter days). The colonization rate for catheters left in place remained low for catheters left in place < 14 days (1.6/100 catheters). Only 11% of catheters were exchanged/removed for reason of "fever," as compared with 23% in phase I.
CONCLUSIONS: AICs significantly reduce the rate of central venous catheter colonization. In addition, the apparent protective effects of the catheter over time permit less frequent exchanges or removals of the catheters, decreasing both patient risk and hospital cost.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10378561     DOI: 10.1378/chest.115.6.1632

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  16 in total

1.  The relationship between methodological trial quality and the effects of impregnated central venous catheters.

Authors:  Christine Geffers; Irina Zuschneid; Tim Eckmanns; Henning Rüden; Petra Gastmeier
Journal:  Intensive Care Med       Date:  2003-02-08       Impact factor: 17.440

Review 2.  Infections associated with medical devices: pathogenesis, management and prophylaxis.

Authors:  Christof von Eiff; Bernd Jansen; Wolfgang Kohnen; Karsten Becker
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 3.  Anti-infective-treated central venous catheters: a systematic review of randomized controlled trials.

Authors:  B S Niël-Weise; T Stijnen; P J van den Broek
Journal:  Intensive Care Med       Date:  2007-10-17       Impact factor: 17.440

4.  Antimicrobial impregnated catheters in the prevention of catheter-related bloodstream infection in hospitalized patients.

Authors:  Sarah K Wassil; Catherine M Crill; Stephanie J Phelps
Journal:  J Pediatr Pharmacol Ther       Date:  2007-04

5.  epic3: national evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England.

Authors:  H P Loveday; J A Wilson; R J Pratt; M Golsorkhi; A Tingle; A Bak; J Browne; J Prieto; M Wilcox
Journal:  J Hosp Infect       Date:  2014-01       Impact factor: 3.926

6.  epic2: National evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England.

Authors:  R J Pratt; C M Pellowe; J A Wilson; H P Loveday; P J Harper; S R L J Jones; C McDougall; M H Wilcox
Journal:  J Hosp Infect       Date:  2007-02       Impact factor: 3.926

Review 7.  Establishing the evidence base for trauma quality improvement: a collaborative WHO-IATSIC review.

Authors:  Catherine J Juillard; Charles Mock; Jacques Goosen; Manjul Joshipura; Ian Civil
Journal:  World J Surg       Date:  2009-05       Impact factor: 3.352

Review 8.  New technologies to prevent intravascular catheter-related bloodstream infections.

Authors:  L A Mermel
Journal:  Emerg Infect Dis       Date:  2001 Mar-Apr       Impact factor: 6.883

9.  Evaluation of a triple-lumen central venous heparin-coated catheter versus a catheter coated with chlorhexidine and silver sulfadiazine in critically ill patients.

Authors:  M N Carrasco; A Bueno; C de las Cuevas; S Jimenez; I Salinas; A Sartorius; T Recio; M Generelo; F Ruiz-Ocaña
Journal:  Intensive Care Med       Date:  2004-01-13       Impact factor: 17.440

Review 10.  Access technique and its problems in parenteral nutrition - Guidelines on Parenteral Nutrition, Chapter 9.

Authors:  K W Jauch; W Schregel; Z Stanga; S C Bischoff; P Brass; W Hartl; S Muehlebach; E Pscheidl; P Thul; O Volk
Journal:  Ger Med Sci       Date:  2009-11-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.